首页 | 本学科首页   官方微博 | 高级检索  
     


Prostate cancer detection using quantitative T2 and T2‐weighted imaging: The effects of 5‐alpha‐reductase inhibitors in men on active surveillance
Authors:Francesco Giganti MD  Giulio Gambarota PhD  Caroline M. Moore MD  Nicola L. Robertson MD  Neil McCartan  Charles Jameson MD  Simon R.J. Bott MD  Mathias Winkler MD  Brandon Whitcher PhD  Ramiro Castro‐Santamaria MD  Mark Emberton MD  Clare Allen MD  Alex Kirkham MD
Affiliation:1. Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK;2. Division of Surgery & Interventional Science, University College London, London, UK;3. INSERM, U1099, Rennes, France;4. Université de Rennes 1, LTSI, Rennes, France;5. Department of Urology, University College London Hospital NHS Foundation Trust, London, UK;6. Department of Pathology, University College London Hospital NHS Foundation Trust, London, UK;7. Department of Urology, Frimley Park Hospital, Surrey, UK;8. Department of Urology, Charing Cross Hospital, Imperial College NHS Trust, London, UK;9. Klarismo, London, UK;10. Department of Mathematics, Imperial College London, UK;11. GlaxoSmithKline, Research and Development, Collegeville, PA, USA
Abstract:
Keywords:prostatic neoplasms  active surveillance  magnetic resonance imaging  quantitative T2  dutasteride  placebo
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号